A new scoring system for the grading of conventional chondrosarcoma: Its clinicopathological significance
Authors:
- 15 September 2022
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 238, 154125
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (19H03444)
This publication has 10 references indexed in Scilit:
- Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal originJournal of Bone Oncology, 2020
- Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade ChondrosarcomaClinical Cancer Research, 2020
- Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single InstitutionSarcoma, 2019
- Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic SarcomaAmerican Journal of Surgical Pathology, 2019
- Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database AnalysisJournal of Orthopaedic Research, 2019
- H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological featuresLaboratory Investigation, 2019
- Local Treatment with Adjuvant Therapy for Central Atypical Cartilaginous Tumors in the Long BonesJournal of Bone and Joint Surgery, 2016
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Prognostic factors in chondrosarcoma of bone.A clinicopathologic analysis with emphasis on histologic gradingCancer, 1977
- Chondrosarcoma of boneCancer, 1952